Hims & Hers vs MEDVi (2026): prices, structure, verdict
On tirzepatide, only MEDVi↗ has a rankable figure: $399 a month all-in; Hims & Hers↗ routes tirzepatide through brand channels without a single compounded cash price — its cost depends on coverage or the manufacturer programs (Zepbound vials $299–$449; Wegovy $349).
Updated 2026-08-10 · figures captured 2026-08-09 · how we verify
On semaglutide, only MEDVi has a rankable figure: $299 a month all-in; Hims & Hers routes semaglutide through brand channels without a single compounded cash price — its cost depends on coverage or the manufacturer programs (Zepbound vials $299–$449; Wegovy $349).
Hims & Hers
- Tirzepatide all-in
- brand channel
- Semaglutide all-in
- brand channel
- 12-mo tirzepatide (best path)
- —
- Membership
- none
- Shipping
- included
- Commitment
- plan recurs
- Cancellation
- plan recurs until cancelled
- Pharmacy
- ✔ brand fulfillment; compounded program closed to new patients
- States
- 50 states
- Insurance
- no
- Evidence
- no public price · 2026-08-05
MEDVi
- Tirzepatide all-in
- $399/mo · flat
- Semaglutide all-in
- $299/mo · flat
- 12-mo tirzepatide (best path)
- $4,788
- Membership
- none
- Shipping
- included
- Commitment
- 12-month plan for the lowest rate
- Cancellation
- 12-month plan applies to lowest rate
- Pharmacy
- not named
- States
- priced differently in CA/NC on some plans
- Insurance
- no
- Evidence
- source-verified · 2026-08-05
The two records, condensed
Hims & Hers: the record, condensed
On tirzepatide, Hims & Hers is a brand channel rather than a priced product: it prescribes the FDA-approved medication, and what you pay depends on coverage or the manufacturer cash programs (Zepbound (LillyDirect↗) at $299–$449).
Hims & Hers routes semaglutide through brand product — no single compounded cash figure exists to rank. The reference prices live one layer down: Wegovy (NovoCare↗), $199–$349 a month cash, or whatever your insurance turns those numbers into.
Operationally at Hims & Hers: shipping included; commitment plan recurs; cancellation plan recurs until cancelled; pharmacy named (brand fulfillment; compounded program closed to new patients); states: 50 states; evidence no public price, captured 2026-08-05. The full record with source and archive links: the Hims & Hers page · visit Hims & Hers ↗
MEDVi: the record, condensed
Start with the load-bearing figure: $399 a month, all-in, is what MEDVi charges for tirzepatide at the 10 mg basis. Because pricing is flat across the ladder (2.5 → 5 → 7.5 → 10 mg (12.5 and 15 mg available)), a dose increase at MEDVi is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $399 is the whole subscription, which makes MEDVi unusually easy to compare and unusually easy to leave.
Context for that figure: it ranks #14 of 17 in the verified tirzepatide index — $184/month above the floor (NexLife↗, $215) — and sits $50 under the brand benchmark (Zepbound (LillyDirect), $449 at maintenance). Annualized, a monthly-billed year here runs $4,788.
Start with the load-bearing figure: $299 a month, all-in, is what MEDVi charges for semaglutide at the 2.4 mg basis. Because pricing is flat across the ladder (0.25 → 0.5 → 1.0 → 1.7 → 2.4 mg), a dose increase at MEDVi is a clinical event and not a billing one. Whatever your prescriber decides, the invoice does not move, which makes this one of the few programs whose headline figure you can actually plan a year around.
Nothing recurs on top: no membership, no platform fee, no “provider access” line. The $299 is the whole subscription, which makes MEDVi unusually easy to compare and unusually easy to leave.
To place the number: #18 of 20 verified programs, with the floor $166/month below at Oak Longevity ($133); the approved-product yardstick (Wegovy (NovoCare)) sits at $349, so the compounded case here is worth $50 a month. A year at this figure: $3,588 monthly-billed.
Operationally at MEDVi: shipping included; commitment 12-month plan for the lowest rate; cancellation 12-month plan applies to lowest rate; pharmacy not publicly named — ask in writing before paying; states: priced differently in CA/NC on some plans; evidence source-verified, captured 2026-08-05. The full record with source and archive links: the MEDVi page · visit MEDVi ↗
Everything besides the price
Coverage: Hims & Hers publishes “50 states”; MEDVi publishes “priced differently in CA/NC on some plans” — for anything short of an explicit 50-state claim, intake is the final word.
Pharmacy transparency splits them: Hims & Hers names its network (brand fulfillment; compounded program closed to new patients); MEDVi does not, which shifts the burden of verification onto your intake questions.
Exit terms: Hims & Hers — plan recurs; plan recurs until cancelled. MEDVi — 12-month plan for the lowest rate; 12-month plan applies to lowest rate.
Evidence: Hims & Hers no public price (captured 2026-08-05); MEDVi source-verified (2026-08-05).
A rule that has held across this index: disclosure predicts disclosure. Whichever of these two publishes more — pharmacies, states, exit terms — is usually the one whose invoice matches its ad.
Switching between Hims & Hers and MEDVi
Prescriptions do not transfer like phone numbers: moving in either direction means completing the destination’s intake and having its prescriber write a new patient-specific prescription. The mechanics that prevent a bad month: confirm the destination serves your state and quotes your current dose in writing before cancelling anything; time the first new shipment to overlap the last old one rather than gap it; cancel the origin per its published terms (Hims & Hers: plan recurs until cancelled; MEDVi: 12-month plan applies to lowest rate) and screenshot the confirmation; and never leave a prepaid balance stranded — which is the standing argument for prepaying only after a program has already earned a few monthly cycles.
Which one, for whom
Cheapest tirzepatide month-to-month: MEDVi ($399).
Cheapest 12-month path: MEDVi at $4,788 (monthly billing).
Cheapest semaglutide: MEDVi ($299).
Pharmacy transparency: Hims & Hers names its fulfillment (brand fulfillment; compounded program closed to new patients); MEDVi does not.
Where a like-for-like price does not exist, the comparison becomes a disclosure contest: the program that answers the pharmacy, states, and maintenance-price questions plainly is the one whose other claims deserve weight.
Verdicts are computed from the records above — recompute them from the dataset. Full profiles: Hims & Hers · MEDVi.
Frequently asked
Which is cheaper, Hims & Hers or MEDVi?
On tirzepatide, only MEDVi has a rankable figure: $399 a month all-in ; Hims & Hers routes tirzepatide through brand channels without a single compounded cash price — its cost depends on coverage or the manufacturer programs (Zepbound vials $299–$449; Wegovy $349). On semaglutide, only MEDVi has a rankable figure: $299 a month all-in ; Hims & Hers routes semaglutide through brand channels without a single compounded cash price — its cost depends on coverage or the manufacturer programs (Zepbound vials $299–$449; Wegovy $349).
Is there a membership fee at Hims & Hers or MEDVi?
Hims & Hers: none. MEDVi: none.
Where do these numbers come from?
From each provider's own published pages, captured 2026-08-05 (Hims & Hers) and 2026-08-05 (MEDVi), normalized to the all-in maintenance basis and archived. Full records: the provider pages and the public dataset.
Is Hims & Hers or MEDVi dose-flat?
Hims & Hers: no flat structure verified — get the maintenance-dose price in writing. MEDVi: yes — flat across doses. Flat pricing turns the advertised number into a ceiling; tiered pricing makes it a floor.
Can I check both Hims & Hers and MEDVi against their sources?
Yes — that is the design. Each record carries a capture date (2026-08-05 / 2026-08-05), a source link, and an archive link in the database; the figures on this page regenerate from those records, so any discrepancy you find is reportable and fixable sitewide in one pass.
What states do Hims & Hers and MEDVi serve?
Hims & Hers: 50 states. MEDVi: priced differently in CA/NC on some plans. Telehealth availability rides on clinician licensure and pharmacy permits, so for anything short of an explicit 50-state claim the enrollment flow is the final word; the state-by-state index adds the known exceptions.
Is shipping included at Hims & Hers and MEDVi?
Hims & Hers: included. MEDVi: included. Cold-chain delivery is a real cost; programs that fold it into the all-in figure remove a checkout surprise, and any separate shipping line belongs in your comparison math before the prices above are treated as equivalent.
Which is more transparent, Hims & Hers or MEDVi?
On the checkable axes: pharmacy named — Hims & Hers yes (brand fulfillment; compounded program closed to new patients), MEDVi no; state list — Hims & Hers published, MEDVi published; cancellation terms — Hims & Hers published, MEDVi published; evidence — no public price vs source-verified. Disclosure predicts disclosure in this market, and the axis where one of these two goes quiet is usually where your intake questions should get loud.